State Street’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-174
| Closed | -$1.23K | – | 4620 |
|
|
2023
Q2 | $1.23K | Hold |
174
| – | – | ﹤0.01% | 4671 |
|
|
2023
Q1 | $4.9K | Hold |
174
| – | – | ﹤0.01% | 4769 |
|
|
2022
Q4 | $11.3K | Hold |
174
| – | – | ﹤0.01% | 4793 |
|
|
2022
Q3 | $42K | Hold |
174
| – | – | ﹤0.01% | 4692 |
|
|
2022
Q2 | $80K | Hold |
174
| – | – | ﹤0.01% | 4607 |
|
|
2022
Q1 | $154K | Buy |
174
+7
| +4% | +$6.46K | ﹤0.01% | 4479 |
|
|
2021
Q4 | $163K | Hold |
167
| – | – | ﹤0.01% | 4428 |
|
|
2021
Q3 | $267K | Sell |
167
-49
| -23% | -$80K | ﹤0.01% | 4246 |
|
|
2021
Q2 | $378K | Buy |
216
+211
| +4,220% | +$392K | ﹤0.01% | 3965 |
|
|
2021
Q1 | $10K | Buy |
+5
| New | +$12.3K | ﹤0.01% | 3973 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$10K | – | 3811 |
|
|
2018
Q1 | $10K | Hold |
2
| – | – | ﹤0.01% | 3739 |
|
|
2017
Q4 | $10K | Buy |
2
+1
| +100% | +$7.03K | ﹤0.01% | 3714 |
|
|
2017
Q3 | $11K | Hold |
1
| – | – | ﹤0.01% | 3743 |
|
|
2017
Q2 | $17K | Hold |
1
| – | – | ﹤0.01% | 3660 |
|
|
2017
Q1 | $24K | Hold |
1
| – | – | ﹤0.01% | 3609 |
|
|
2016
Q4 | $26K | Hold |
1
| – | – | ﹤0.01% | 3597 |
|
|
2016
Q3 | $31K | Hold |
1
| – | – | ﹤0.01% | 3509 |
|
|
2016
Q2 | $22K | Hold |
1
| – | – | ﹤0.01% | 3650 |
|
|
2016
Q1 | $24K | Hold |
1
| – | – | ﹤0.01% | 3659 |
|
|
2015
Q4 | $15K | Hold |
1
| – | – | ﹤0.01% | 3669 |
|
|
2015
Q3 | $16K | Hold |
1
| – | – | ﹤0.01% | 3675 |
|
|
2015
Q2 | $31K | Sell |
1
-1
| -50% | -$24.4K | ﹤0.01% | 3639 |
|
|
2015
Q1 | $39K | Hold |
2
| – | – | ﹤0.01% | 3596 |
|
|
2014
Q4 | $51K | Hold |
2
| – | – | ﹤0.01% | 3587 |
|
|
2014
Q3 | $51K | Hold |
2
| – | – | ﹤0.01% | 3569 |
|
|
2014
Q2 | $46K | Sell |
2
-32
| -94% | -$817K | ﹤0.01% | 3551 |
|
|
2014
Q1 | $1.01M | Buy |
34
+15
| +79% | +$523K | ﹤0.01% | 3255 |
|
|
2013
Q4 | $668K | Buy |
19
+1
| +6% | +$23.7K | ﹤0.01% | 3317 |
|
|
2013
Q3 | $435K | Buy |
18
+13
| +260% | +$419K | ﹤0.01% | 3364 |
|
|
2013
Q2 | $223K | Buy |
+5
| New | +$280K | ﹤0.01% | 3325 |
|
Other funds holding BIOL
State Street's BIOL Position: Q3 2023 in Review
State Street sold out of Biolase (BIOL) in Q3 2023, closing a stake of 174 shares — an estimated $1.23K sold.
State Street first reported a position in BIOL in Q2 2013 and held it in 30 quarters. The position peaked at $1.01M in Q1 2014. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.
- State Street reported no remaining Biolase position as of Q3 2023 after selling out during the quarter.
- State Street sold 174 Biolase shares in Q3 2023, an estimated $1.23K.
- State Street first reported a position in Biolase in Q2 2013 and held it in 30 quarters.
- State Street's Biolase position peaked at $1.01M in Q1 2014.
- 12 funds tracked by Wall St. Rank held Biolase as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.